Live feed11:42:00·6mPRReleasevia QuantisnowEncaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1ByQuantisnow·Wall Street's wire, on your screen.BBIO· BridgeBio Pharma Inc.Health Care
